Enfortumab vedotin in combination with pembrolizumab is a potential new standard of care for 1L la/mUC

Enzalutamide monotherapy prolongs MFS compared to leuprolide alone in men with high-risk biochemically recurrent PC

Combination of cabozantinib and atezolizumab shows moderate activity in treating metastatic adrenocortical carcinoma

Novel therapies and combinations in ovarian cancer

What's new on ADCs in management of advanced NSCLC

Multiple myeloma treatment in Dakar: Epidemiological, diagnostic, and therapeutic aspects

Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC

Genetic testing and targeted therapy in Ivory Coast

Clinical Research Mentorship Program for LMICs

Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy

T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer

CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer